All Clinical Trials
A Natural History Observation and Registry Study of Macular Telangiectasia Type 2: The MACTEL StudySince 2005, a group of scientists and clinicians from around the world have identified and are studying hundreds of persons with MacTel Type 2. Progress has been made to find ways to help prevent the condition from developing and to find potential treatment(s) but more work is needed. Special scientists (geneticists) are working to understand if this disorder is inherited (passed down from your parents) and basic scientists are working to understand what happens to the eye tissue inside a MacTel eye. The purpose of this study is to identify persons with MacTel Type 2, and their affected family members to create a Registry of persons with MacTel Type 2. This Registry will be used to study participants with MacTel Type 2 now and may be used in the future to identify persons to be in a study that may help find a way to prevent or treat this eye condition. We also wish to keep in contact with persons who have told by their MacTel doctor that they have MacTel Type 2. In this document, the word “affected” means that it has been confirmed that you have MacTel Type 2. These persons may also be referred to as “Probands” when they are the first person in the family to be diagnosed with the disorder. “Unaffected” means that at this time, there is no evidence of MacTel Type 2. Who Can Participate?1. Must have a confirmed clinical diagnosis of MacTel Type 2. 2. Must be 18 years of age or older. Principal Investigator, Study ID, Keywords STU00206885 For questions about this study, contact: |